SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
45 hedge funds and large institutions have $205M invested in Syros Pharmaceuticals, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 14 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
45
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$1.54M | |
| 3 | +$400K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$252K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$225K |
Top Sellers
| 1 | -$3.15M | |
| 2 | -$323K | |
| 3 | -$170K | |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$143K |
| 5 |
JPMorgan Chase & Co
New York
|
-$136K |